Yael Hirsch‐Moverman

2.7k total citations
61 papers, 1.6k citations indexed

About

Yael Hirsch‐Moverman is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Yael Hirsch‐Moverman has authored 61 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Infectious Diseases, 44 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Yael Hirsch‐Moverman's work include Tuberculosis Research and Epidemiology (42 papers), Pneumocystis jirovecii pneumonia detection and treatment (27 papers) and HIV/AIDS Research and Interventions (23 papers). Yael Hirsch‐Moverman is often cited by papers focused on Tuberculosis Research and Epidemiology (42 papers), Pneumocystis jirovecii pneumonia detection and treatment (27 papers) and HIV/AIDS Research and Interventions (23 papers). Yael Hirsch‐Moverman collaborates with scholars based in United States, South Africa and Canada. Yael Hirsch‐Moverman's co-authors include Paul W. Colson, Julie Franks, Amrita Daftary, Wafaa El‐Sadr, James Bethel, Sharon Mannheimer, Paul Weinfurter, C. Robert Horsburgh, Timothy R. Sterling and Andrea A. Howard and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Yael Hirsch‐Moverman

61 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yael Hirsch‐Moverman United States 20 1.4k 1.1k 413 269 129 61 1.6k
Peter Bock South Africa 20 1.2k 0.9× 889 0.8× 263 0.6× 518 1.9× 105 0.8× 70 1.6k
Ludwig Apers Belgium 19 835 0.6× 677 0.6× 323 0.8× 122 0.5× 69 0.5× 48 1.2k
Greg J. Fox Australia 24 1.2k 0.9× 871 0.8× 364 0.9× 166 0.6× 53 0.4× 95 1.7k
W. J. Burman United States 17 2.2k 1.6× 1.8k 1.7× 470 1.1× 416 1.5× 300 2.3× 24 2.5k
Anita M. Loughlin United States 18 1.1k 0.8× 1.2k 1.2× 224 0.5× 262 1.0× 82 0.6× 36 1.7k
Catherine C. McGowan United States 25 1.1k 0.8× 733 0.7× 208 0.5× 222 0.8× 76 0.6× 84 1.7k
Sharath Burugina Nagaraja India 23 913 0.7× 712 0.7× 281 0.7× 176 0.7× 36 0.3× 128 1.4k
Degu Jerene Ethiopia 23 1.3k 0.9× 755 0.7× 178 0.4× 260 1.0× 41 0.3× 104 1.5k
Meaza Demissie Ethiopia 25 1.3k 0.9× 1.0k 0.9× 362 0.9× 231 0.9× 49 0.4× 72 1.9k
Zara Shubber United Kingdom 25 1.7k 1.2× 1.1k 1.0× 88 0.2× 340 1.3× 151 1.2× 46 2.1k

Countries citing papers authored by Yael Hirsch‐Moverman

Since Specialization
Citations

This map shows the geographic impact of Yael Hirsch‐Moverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yael Hirsch‐Moverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yael Hirsch‐Moverman more than expected).

Fields of papers citing papers by Yael Hirsch‐Moverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yael Hirsch‐Moverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yael Hirsch‐Moverman. The network helps show where Yael Hirsch‐Moverman may publish in the future.

Co-authorship network of co-authors of Yael Hirsch‐Moverman

This figure shows the co-authorship network connecting the top 25 collaborators of Yael Hirsch‐Moverman. A scholar is included among the top collaborators of Yael Hirsch‐Moverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yael Hirsch‐Moverman. Yael Hirsch‐Moverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wademan, Dillon T., Yael Hirsch‐Moverman, Lario Viljoen, et al.. (2025). Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy. PubMed. 2(1). 13–18. 1 indexed citations
2.
Mugenyi, Levicatus, et al.. (2024). Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda. PLoS ONE. 19(1). e0296239–e0296239. 2 indexed citations
3.
Hirsch‐Moverman, Yael, et al.. (2024). Guidelines for tuberculosis screening and preventive treatment among pregnant and breastfeeding women living with HIV in PEPFAR-supported countries. PLoS ONE. 19(4). e0296993–e0296993. 2 indexed citations
4.
Strauß, M., Dillon T. Wademan, Graeme Hoddinott, et al.. (2023). TB preventive therapy preferences among children and adolescents. The International Journal of Tuberculosis and Lung Disease. 27(7). 520–529. 7 indexed citations
5.
Wademan, Dillon T., Lario Viljoen, Karen Du Preez, et al.. (2022). Reasons for poor uptake of TB preventive therapy in South Africa. Public Health Action. 12(4). 159–164. 17 indexed citations
6.
7.
Hirsch‐Moverman, Yael, et al.. (2019). Determinants of alcohol use among people living with HIV initiating isoniazid preventive therapy in Ethiopia. Drug and Alcohol Dependence. 204. 107465–107465. 3 indexed citations
8.
Hirsch‐Moverman, Yael, et al.. (2017). Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. PLoS ONE. 12(8). e0182185–e0182185. 83 indexed citations
9.
10.
Daftary, Amrita, Mike Frick, Yael Hirsch‐Moverman, et al.. (2016). Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. The International Journal of Tuberculosis and Lung Disease. 20(4). 430–434. 56 indexed citations
11.
Royce, Rachel A., Jonathan E. Golub, Amy L. Davidow, et al.. (2015). Risk factors for transmission of tuberculosis among United States-born African Americans and Whites. The International Journal of Tuberculosis and Lung Disease. 19(12). 1485–1492. 10 indexed citations
12.
Marks, Suzanne M., Jennifer Flood, Barbara Seaworth, et al.. (2014). Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007. Emerging infectious diseases. 20(5). 812–821. 127 indexed citations
13.
Hirsch‐Moverman, Yael, Robin Shrestha-Kuwahara, James Bethel, et al.. (2014). Latent tuberculous infection in the United States and Canada: who completes treatment and why?. The International Journal of Tuberculosis and Lung Disease. 19(1). 31–38. 51 indexed citations
14.
15.
Dorman, Susan E., Robert Belknap, Edward A. Graviss, et al.. (2013). Interferon-γ Release Assays and Tuberculin Skin Testing for Diagnosis of Latent Tuberculosis Infection in Healthcare Workers in the United States. American Journal of Respiratory and Critical Care Medicine. 189(1). 77–87. 146 indexed citations
16.
Colson, Paul W., Yael Hirsch‐Moverman, Jim Bethel, et al.. (2013). Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada. The International Journal of Tuberculosis and Lung Disease. 17(4). 473–479. 35 indexed citations
17.
Beavers, Suzanne F., Jennifer Flood, Paul Weinfurter, et al.. (2012). Tuberculosis Mortality In The United States: How Can It Be Prevented?. A6062–A6062. 3 indexed citations
18.
Horsburgh, C. Robert, Stefan Goldberg, James Bethel, et al.. (2009). Latent TB Infection Treatment Acceptance and Completion in the United States and Canada. CHEST Journal. 137(2). 401–409. 172 indexed citations
19.
Hirsch‐Moverman, Yael, Amrita Daftary, Julie Franks, & Paul W. Colson. (2008). Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada.. PubMed. 12(11). 1235–54. 153 indexed citations
20.
Sarmiento, Kelly, et al.. (2006). Help-seeking behavior of marginalized groups: a study of TB patients in Harlem, New York.. PubMed. 10(10). 1140–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Bock Breakdown of academic impact, for papers by Ludwig Apers Breakdown of academic impact, for papers by Greg J. Fox Breakdown of academic impact, for papers by W. J. Burman Breakdown of academic impact, for papers by Anita M. Loughlin Breakdown of academic impact, for papers by Catherine C. McGowan Breakdown of academic impact, for papers by Sharath Burugina Nagaraja Breakdown of academic impact, for papers by Degu Jerene Breakdown of academic impact, for papers by Meaza Demissie Breakdown of academic impact, for papers by Zara Shubber
Rankless by CCL
2026